Salzburg, Austria

Nicole Wopfner

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nicole Wopfner: Innovator in Allergen Research

Introduction

Nicole Wopfner is a prominent inventor based in Salzburg, Austria. She has made significant contributions to the field of allergen research, focusing on the development of hypoallergenic molecules and allergen fragments. With a total of 2 patents, her work is paving the way for advancements in allergy treatments.

Latest Patents

Nicole's latest patents include innovative solutions for allergy management. The first patent, titled "Allergen Fragments," relates to a peptide derived from the ragweed pollen allergen Amb a (1). This peptide comprises between 6 to 50 amino acid residues and is used in pharmaceutical preparations for allergy treatment. The second patent, "Hypoallergenic Molecules," describes a hypoallergenic molecule consisting of Bet v Ia or an allergen with at least 40% identity to Bet v Ia. This invention includes mutations of at least four amino acid residues in the region of amino acids 100 to 125 of Bet v Ia or its corresponding region of the allergen.

Career Highlights

Nicole Wopfner is currently employed at Biomay AG, where she continues her research and development in allergen-related innovations. Her work is instrumental in creating safer and more effective allergy treatments.

Collaborations

Nicole collaborates with esteemed colleagues, including Barbara Bohle and Fatima Ferreira, who contribute to her research efforts and enhance the impact of her inventions.

Conclusion

Nicole Wopfner's contributions to allergen research through her innovative patents are significant. Her work at Biomay AG and collaborations with fellow researchers highlight her commitment to advancing allergy treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…